VZ5-48458-22136
2 vaccinations
2 coded responses
9 check-ins
2 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 191 / PA
- Registered
- 2021-02-06
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-09
Dose 1 — Moderna
-
2021-02-06
Registered in v-safe
-
2021-02-06
Dose 2 — Moderna
-
2021-02-06
Survey response — day 0, dose 2MedDRA: Injection site warmth — Feeling: Fair · Site: Pain, Swelling · Joint pains, Fatigue or tirednessFree text: Increased skin temperature near injection siteMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-07
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain, Redness, Swelling · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesAdult check-in
-
2021-02-08
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Redness · Headache, Joint pains, Fatigue or tiredness, Nausea · Be unable to workAdult check-in
- 2021-02-09
- 2021-02-20
- 2021-03-13
- 2021-05-10
- 2021-08-07
-
2022-02-06
Survey response — 12 months, dose 2MedDRA: Office visit, Pregnancy — Feeling: Good · Get care from a doctor or other healthcare professionalFree text: Symptoms: Pregnancy · Healthcare visit (other): RoutineMedDRA releases: 2024-11 · check-in free text available
-
2022-02-06
Report sent to call center — 12 months, dose 2Get care from a doctor or other healthcare professional1 call case(s)
-
2022-02-11
Call successfulNot applicable (accidental reporting or does not believe symptoms are related to vaccine)
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-09 | Moderna | |
| 2 | 2021-02-06 | Moderna |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-02-06 | Successful 2022-02-11 |
Not applicable (accidental reporting or does not believe symptoms are related to vaccine) |
Free text
Release 3 — day 0, dose 2
Systemic reaction (other): Increased skin temperature near injection site
Release 11 — 12 months, dose 2
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Office visit | · | · | ✓ |
| SD | Pregnancy | · | · | ✓ |
| SRO | Injection site warmth | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release